Skip to content
Acceleron Pharma

Investors/Media

Press Releases

Filter Releases
 
Press Releases
Date Title and Summary View
Mar 11, 2008
CAMBRIDGE, Mass. – March 11, 2008 – Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, today announced that John Knopf, Ph.D., Chief Executive Officer of Acceleron will provide a corporate presentation at the Cowen and Com...
Feb 25, 2008
BioCentury Feb 25, 2008
Feb 21, 2008
BioWorld Today, Feb 21, 2008
Feb 20, 2008
CAMBRIDGE, Mass. & SUMMIT, N.J.– Feb. 20, 2008 – Acceleron Pharma, Inc. and Celgene Corporation today announced a worldwide strategic collaboration for the joint development and commercialization of ACE-011, a first-in-class, novel bone-forming compound. The collaboration combines both companies’ resources and commitment to...
Jan 23, 2008
Cambridge, Mass. – January 23, 2008 – Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, today announced that it was selected to receive a Biotech Investment Award from the Multiple Myeloma Research Foundation to support the...
Nov 20, 2007
Cambridge, Mass. – November 20, 2007 - Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, today announced that John Knopf, Ph.D., Chief Executive Officer at Acceleron, will provide a corporate presentation at the Lazard Capital Ma...
Nov 1, 2007
Cambridge, Mass. – November 1, 2007 – Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, today announced that it will provide a corporate presentation at the Massachusetts Biotechnology Council’s (MBC) 9th Annual MASS ...
Oct 31, 2007
BioWorld Today, October 31, 2007
Oct 31, 2007
Cambridge, Mass. – October 31, 2007 – Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, today announced that John Knopf, Ph.D., Chief Executive Officer of Acceleron, will provide a corporate presentation at the Acumen Bio...
Oct 30, 2007
Cambridge, Mass. – October 30, 2007 – Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, today announced it raised $31M in a Series C financing. Bessemer Venture Partners led the round along with other new investors MPM BioE...
Oct 18, 2007
Link to article
Oct 18, 2007
Cambridge, Mass. – October 18, 2007 – Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, today announced results of a preclinical study with ACE-031, the company’s lead product for the treatment of muscular dystrophy, ...
Oct 4, 2007
Cambridge, Mass. – October 4, 2007 – Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, announced that the Web Marketing Association (“WMA”) awarded a “Pharmaceutical Industry Standard of Excellence”...
Oct 2, 2007
Cambridge, Mass. – October 2, 2007 – Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, today announced that John Knopf, Ph.D., Chief Executive Officer of Acceleron, will provide a corporate presentation at the Natixis Bleic...
Sep 24, 2007
Cambridge, Mass. – September 24, 2007 – Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, today announced that Niels Borgstein, M.D. has joined Acceleron as Vice President, Medical Research. Dr. Borgstein has more than 10...
= add release to Briefcase